These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1198536)

  • 1. Proceedings: Purification of tissue activator using affinity adsorption on fibrin and hydrophobic interaction chromatography. Effect of fibrin on the enzymatic properties of the activator.
    Wallén P; Wiman B
    Thromb Diath Haemorrh; 1975 Nov; 34(2):609. PubMed ID: 1198536
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid purification of a high-affinity plasminogen activator from human blood plasma by specific adsorption on fibrin/Celite.
    Husain SS; Lipinski B; Greuwich V
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4265-9. PubMed ID: 6270665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and purification of plasminogen activator from Yoshida ascites Sarcoma of rats.
    Nulkar MW; Pawse AR
    Indian J Biochem Biophys; 1991 Feb; 28(1):46-51. PubMed ID: 1905268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and identification of two structural variants of porcine tissue plasminogen activator by affinity adsorption on fibrin.
    Wallén P; Bergsdorf N; Rånby M
    Biochim Biophys Acta; 1982 Nov; 719(2):318-28. PubMed ID: 6891267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of tissue plasminogen activator by denatured proteins and fibrin clots: a possible additional role for plasminogen activator?
    Radcliffe R; Heinze T
    Arch Biochem Biophys; 1981 Oct; 211(2):750-61. PubMed ID: 6458244
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stability of tissue plasminogen activator].
    Liutova LV; Andreenko GV; Shimonaeva EE
    Vopr Med Khim; 1985; 31(1):97-9. PubMed ID: 3920826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D
    Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986
    [No Abstract]   [Full Text] [Related]  

  • 8. Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture.
    Bykowska K; Rijken DC; Collen D
    Thromb Haemost; 1981 Oct; 46(3):642-4. PubMed ID: 7198301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of plasminogen activator in human plasma using the method of fibrin/celite column chromatography--with special reference to the determination of fibrin adsorbable tissue-plasminogen activator by ELISA].
    Ieko M
    Hokkaido Igaku Zasshi; 1985 Nov; 60(6):834-47. PubMed ID: 4085966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stachybotrydial selectively enhances fibrin binding and activation of Glu-plasminogen.
    Sasaoka M; Wada Y; Hasumi K
    J Antibiot (Tokyo); 2007 Nov; 60(11):674-81. PubMed ID: 18057696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolation and characteristics of urokinase-type plasminogen activator from a culture of human embryo lung fibroblasts].
    Shevelev AIa; Barshevskaia TN; Belogurov AA; Kratasiuk GA; Goriunova LE
    Mol Biol (Mosk); 1986; 20(3):778-88. PubMed ID: 3088432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular interactions during fibrinolysis. Search for new plasminogen activators].
    Maksimenko AV
    Mol Biol (Mosk); 1995; 29(1):38-60. PubMed ID: 7723763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.
    Lijnen HR; Soria J; Soria C; Collen D; Caen JP
    Thromb Haemost; 1984 Feb; 51(1):108-9. PubMed ID: 6539000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stimulatory capacity of soluble fibrin prepared from high and low molecular weight fibrinogen on plasminogen activation.
    Halvorsen S; Skjønsberg OH; Godal HC
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):133-7. PubMed ID: 8457641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the binding to fibrin of urokinase and tissue plasminogen activator.
    Thorsen S; Glas-Greenwalt P; Astrup T
    Thromb Diath Haemorrh; 1972 Aug; 28(1):65-74. PubMed ID: 4672651
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterisation of the vascular plasminogen activator from the pig ear.
    Klöcking HP; Astedt B; Gerlach D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):851-61. PubMed ID: 6083962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methods of derivation and physico-chemical properties of plasminogen activators].
    Makogonenko EM
    Ukr Biokhim Zh (1978); 1983; 55(3):344-54. PubMed ID: 6191419
    [No Abstract]   [Full Text] [Related]  

  • 19. [Some properties of the tissue plasminogen activators from the pig heart and ovary (author's transl)].
    Fujimoto K
    Nihon Ketsueki Gakkai Zasshi; 1975 Apr; 38(2):132-42. PubMed ID: 1242587
    [No Abstract]   [Full Text] [Related]  

  • 20. Purification and properties of a plasminogen activator from pig heart.
    Cole ER; Bachmann FW
    J Biol Chem; 1977 Jun; 252(11):3729-37. PubMed ID: 863901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.